![](https://investorshub.advfn.com/uicon/591374.png?cb=1485035485)
Friday, February 10, 2017 1:08:37 PM
Starting Phase 1 FDA trials for psoriasis creme, skin cancer creme, Multiple Myeloma sublingual tablet, and/or PTSD sublingual tablet will, IMHO, put us above $10.
Once those trials go well and we start Phase 2 FDA trials, I'm thinking $20+.
By then the pro analysts will have initiated coverage and there we be a share price consensus. Institutional owners will step up and how high it can go is anyone's guess.
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM